Therapy of Subclinical Mastitis during Lactation
| dc.citation.issue | 2 | |
| dc.citation.volume | 11 | |
| dc.contributor.author | McDougall S | |
| dc.contributor.author | Clausen LM | |
| dc.contributor.author | Hussein HM | |
| dc.contributor.author | Compton CWR | |
| dc.contributor.editor | Krömker V | |
| dc.coverage.spatial | Switzerland | |
| dc.date.accessioned | 2024-01-18T19:22:57Z | |
| dc.date.accessioned | 2024-07-25T06:51:30Z | |
| dc.date.available | 2022-02-07 | |
| dc.date.available | 2024-01-18T19:22:57Z | |
| dc.date.available | 2024-07-25T06:51:30Z | |
| dc.date.issued | 2022-02-07 | |
| dc.description.abstract | This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells/mL) that had an intramammary infection were randomly assigned at cow level to no treatment (Control; n = 80 glands), intramammary infusion of 200 mg cloxacillin sodium on three occasions at 48 h intervals (3 × 48 h; n = 273 glands), five occasions at 24 h intervals (5 × 24 h; n = 279 glands), or on five occasions at 48 h intervals (5 × 48 h; n = 72 glands). Glands were resampled at 21 (±3) and 28 (±3) days after initiation of treatment. The gland-level cure rate for any pathogen was 5/80 (6.2%), 139/173 (49.8%), 172/297 (61.6%) and 58/72 (80.6%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. The cure rate for major pathogens (defined as Staphylococcus aureus or Streptococcus spp.) was 4/52 (7.7%), 84/197 (42.6%), 96/183 (52.5%) and 36/48 (75%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. We conclude that treatment was superior to no treatment, and bacteriological cure rate was higher with the 5 × 24 h protocol than for the 3 × 48 h protocol and was higher with the 5 × 48 h than the 5 × 24 h protocol. | |
| dc.description.confidential | false | |
| dc.edition.edition | February 2022 | |
| dc.format.pagination | 209- | |
| dc.identifier.author-url | https://www.ncbi.nlm.nih.gov/pubmed/35203812 | |
| dc.identifier.citation | McDougall S, Clausen LM, Hussein HM, Compton CWR. (2022). Therapy of Subclinical Mastitis during Lactation.. Antibiotics (Basel). 11. 2. (pp. 209-). | |
| dc.identifier.doi | 10.3390/antibiotics11020209 | |
| dc.identifier.eissn | 2079-6382 | |
| dc.identifier.elements-type | journal-article | |
| dc.identifier.issn | 2079-6382 | |
| dc.identifier.number | 209 | |
| dc.identifier.pii | antibiotics11020209 | |
| dc.identifier.uri | https://mro.massey.ac.nz/handle/10179/71035 | |
| dc.language | eng | |
| dc.publisher | MDPI (Basel, Switzerland) | |
| dc.publisher.uri | https://www.mdpi.com/2079-6382/11/2/209 | |
| dc.relation.isPartOf | Antibiotics (Basel) | |
| dc.rights | (c) 2022 The Author/s | |
| dc.rights | CC BY 4.0 | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Staphylococcus aureus | |
| dc.subject | Streptococcus uberis | |
| dc.subject | cloxacillin | |
| dc.subject | duration | |
| dc.subject | frequency | |
| dc.subject | mastitis | |
| dc.subject | subclinical | |
| dc.subject | therapy | |
| dc.title | Therapy of Subclinical Mastitis during Lactation | |
| dc.type | Journal article | |
| pubs.elements-id | 451267 | |
| pubs.organisational-group | Other |
Files
Original bundle
1 - 1 of 1
